0
0
Paris, November 27, 2025 – A highly pathogenic bird flu virus circulating among wild birds, poultry, and mammals could spark a pandemic worse than COVID-19 if it mutates to enable sustained human-to-human transmission, according to Dr. Marie-Anne Rameix-Welti, director of the respiratory infections center at France’s Institut Pasteur. This warning comes amid ongoing global outbreaks that have culled hundreds of millions of birds, disrupted food supplies, and led to rare but severe human cases, with the World Health Organization reporting nearly 1,000 human infections since 2003 and a 48% mortality rate. While the immediate risk to the public remains low, experts stress the need for heightened surveillance and preparedness.
Key Findings from Institut Pasteur
Dr. Rameix-Welti highlighted the H5 subtype of avian influenza, particularly H5N1, as the primary concern due to its spread across species, including recent detections in U.S. dairy cows and poultry. Unlike seasonal H1 and H3 flu strains, for which most people have some immunity through prior exposure or vaccination, humans lack antibodies against H5 bird flu, mirroring the immunity gap at the start of COVID-19. This strain has caused massive poultry culls worldwide, with economic ripple effects from supply shortages and price hikes, yet human cases stay sporadic, typically linked to direct animal contact.
The virus’s adaptability alarms researchers; it has infected mammals like seals and cats, raising fears of further evolution toward human transmission. In 2025 alone, global health agencies logged 26 human H5N1 cases by early August, including 11 deaths mainly in Cambodia, India, and Mexico, all tied to poultry or wild bird exposure. No person-to-person spread has been confirmed, but the virus’s high lethality—far exceeding COVID-19’s roughly 0.1% fatality rate—prompts urgent monitoring.
Expert Commentary and Perspectives
Dr. Rameix-Welti, speaking from her Paris lab, stated, “A pandemic caused by bird flu would likely be very severe, potentially even more so than the pandemic we experienced,” citing influenza’s ability to kill healthy adults and children, unlike COVID-19’s heavier toll on vulnerable groups. The Institut Pasteur, which pioneered COVID-19 testing protocols shared with the WHO, underscores its credibility in respiratory virus research.
Other virologists echo this caution. Dr. Angela Rasmussen, a virologist at the University of Saskatchewan not involved in the Pasteur work, noted in recent analyses that while H5N1’s pandemic risk persists due to its global avian presence, current human cases remain mild in North America, with no sustained transmission. Conversely, public health experts like Dr. Amesh Adalja from Johns Hopkins warn that gaps in U.S. response to ongoing outbreaks signal vulnerabilities in broader preparedness. Leading virologists from 40 countries recently urged immediate action on surveillance and vaccines, citing H5N1’s 50% historical human mortality.
Background and Global Context
Avian influenza A(H5N1) first jumped to humans in 1997 in Hong Kong, but clade 2.3.4.4b strains since 2020 have driven unprecedented outbreaks across Africa, Europe, Asia, and the Americas, spilling into mammals. By mid-2025, the U.S. reported 70 human cases—mostly mild eye or respiratory symptoms in farm workers exposed to infected cows or poultry—with one death in an older patient with comorbidities. Cambodia alone saw 83 cases since 2023, with a 59% fatality rate, often in children exposed to backyard poultry.
WHO data shows 986 human H5N1 cases globally from 2003 to July 2025, with 473 deaths, concentrated in Egypt, Indonesia, and Vietnam historically. Factors like intensified wild bird migration and industrial farming amplify spread, but pasteurization kills the virus in milk, and proper cooking eliminates it in poultry, reassuring food safety experts.
Public Health Implications
If H5N1 gains efficient human transmission, populations could face overwhelming severe illness, straining healthcare systems more than COVID-19 due to limited natural immunity. Everyday risks include farm workers handling infected animals; consumers should cook poultry thoroughly and avoid raw milk, though general population risk stays low. Governments hold pre-pandemic vaccine antigens and antiviral stockpiles like oseltamivir (Tamiflu), enabling faster production than for COVID-19—millions of doses within weeks for key groups.
Practical steps for readers: Avoid contact with sick birds or mammals, report dead wild birds to authorities, and stay current on flu vaccines, which offer partial cross-protection. Enhanced farm biosecurity and global surveillance, as pushed by WHO’s flu network, could curb spillovers.
Limitations and Counterarguments
Despite warnings, pandemic odds remain low; H5N1 requires multiple mutations for airborne human spread, and no such shift has occurred despite decades of circulation. U.S. cases dropped by mid-2025, prompting CDC to end its emergency response, with experts noting seasonal patterns and mild outcomes. Vaccine challenges persist: egg-based production faces shortages from bird flu itself, prior H5 trials showed weak immunity, and public hesitancy could limit uptake.
Critics argue overemphasis on lab gain-of-function research diverts from natural evolution risks, while antivirals face resistance concerns. Ongoing studies, like Institut Pasteur’s microfluidics for reassortment analysis, aim to quantify these threats precisely.
References
